CONMED Corp - 8-K Filing

CONMED Corp reports Q3 2026 sales of $335.6 million and updates full-year guidance upward for organic constant currency growth. (Items: 2.02 Results of Operations and Financial ConditionOn October 28, 2026, CONMED Corporation issued a press release announcing financial results for, 9.01 Financial Statements and Exhibits(d) ExhibitsThe following exhibits are included herewith:Exhibit No)

SEC EDGAR · October 28, 2026, 20:09 UTC

Tickers: $CNMD

Read the full article at SEC EDGAR

Part of the story JOHNSON & JOHNSON - 8-K Filing (37 articles)

More Regulatory news

MiNK Therapeutics, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:49 UTC
SusGlobal Energy Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:42 UTC
Ideal Power Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:25 UTC
DIGI INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:23 UTC
ZeroStack Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 14:22 UTC
Sound Point Meridian Capital, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:22 UTC
Boost Run Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
INTERFACE INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Neonode Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Virtuix Holdings Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC